North America Point-of-care Diagnostic Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Point-of-care testing is medical diagnostic testing or near point-of-care testing. Point-of-care tests are simple medical tests that are performed and develop new technology to mask the complexity. Connectivity is an important part of the point-of-care market. North America is accounting for the most significant market share.

North America Point-of-care Diagnostic Market Segments size & growth:

The market is valued at $ 7.576 billion in 2017 and is projected to $ 13.148 billion by 2024 at a CAGR of 10.2%. The significant factors that are driving the growth of the market include an increase in awareness and inclination towards home health care, and prevalence of lifestyle and infectious disease and demand for the market is expected to grow in the further years. Rapid growth in ageing population, advancements in technology and increase in the number of chronic diseases.

North America Point-of-care Diagnostic Market Share:

Point-of-care diagnostics market is categorised by by-product, mode of delivery and end user. By by-product, it is segmented into infectious disease, glucose monitoring kit, oncology markers, coagulation, drugs of abuse and blood gas testing and others. Based on the mode of delivery the market is categorised into OTC testing and prescription. And based on end users the market is segmented into research laboratories, home health care, and hospitals. As by-product categorises the market, mode of delivery and end user the market equally constitutes the market share in all the categories like hospitals, research laboratories and home health care, testing and monitoring. Geographically, North America is accounting for largest share for point-of-care followed by Europe. The USA holds the most significant market share which is 3/4^th of local revenue. Canada is to register Lucrative growth during forecast owing to the research carried by universities for incorporation of advancements in POC diagnostics.

North America Point-of-care Diagnostic Market Trends:

• Roche, Alere, Abbott, and Siemens are the ones which are the most significant companies regarding point-of-care diagnostics market revenues and these companies together make three-fourths of entire POC diagnostics market.
• Waltham, MA-based Alere secured the second market position and participated in nearly all the POC segments but dominates in cardiac markers.

North America Point-of-care Diagnostic Market Research Reports Include:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by the analyst to the individual and organisation to have a better foothold in the market.

The primary market players are:

• Abbott Laboratories
• Siemens AG
• Johnson & Johnson
• Alere Inc.
• Nova Biomedical
• Roche Diagnostics